CUR treatment can significantly inhibit the proliferation of SMMC-7721 and HepG2 hepatoma cells, increase the activity of caspase-3, and inhibit the PTEN/PI3K/AKT signaling pathway by downregulating the expression of DJ-1 (Han et al., 2020). The gene discussed is AKT1; the disease is hepatocellular carcinoma.